NDC 65121-712

Curefini

Petrolatum, Cod Liver

Curefini is a Topical Ointment in the Human Otc Drug category. It is labeled and distributed by Pure Source, Llc. The primary component is Petrolatum; Cod Liver Oil.

Product ID65121-712_7c5dc903-c86c-103c-e053-2991aa0aa534
NDC65121-712
Product TypeHuman Otc Drug
Proprietary NameCurefini
Generic NamePetrolatum, Cod Liver
Dosage FormOintment
Route of AdministrationTOPICAL
Marketing Start Date2013-01-17
Marketing CategoryOTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
Application Numberpart347
Labeler NamePure Source, LLC
Substance NamePETROLATUM; COD LIVER OIL
Active Ingredient Strength300 mg/mL; mg/mL
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 65121-712-64

120 mL in 1 JAR (65121-712-64)
Marketing Start Date2017-02-07
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 65121-712-64 [65121071264]

Curefini OINTMENT
Marketing CategoryOTC monograph final
Application Numberpart347
Product TypeHUMAN OTC DRUG
Marketing Start Date2017-02-07

NDC 65121-712-65 [65121071265]

Curefini OINTMENT
Marketing CategoryOTC monograph final
Application Numberpart347
Product TypeHUMAN OTC DRUG
Marketing Start Date2017-02-07

Drug Details

Active Ingredients

IngredientStrength
PETROLATUM300 mg/mL

OpenFDA Data

SPL SET ID:81059272-b681-4440-8cdf-a8227eadd0c1
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1440007
  • NDC Crossover Matching brand name "Curefini" or generic name "Petrolatum, Cod Liver"

    NDCBrand NameGeneric Name
    65121-712Curefinipetrolatum, cod liver
    69981-712CUREFINIPETROLATUM, COD LIVER
    79974-202CUREFINIPetrolatum, Cod Liver Oil
    69981-710CURACID Dermal for cuts and burnsPETROLATUM, COD LIVER
    69981-704CUREFINI DermalPETROLATUM, COD LIVER
    69981-754Curefini DermalPETROLATUM, COD LIVER
    65121-208Senophile DermalPETROLATUM, COD LIVER

    Trademark Results [Curefini]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    CUREFINI
    CUREFINI
    85691942 4409741 Live/Registered
    REV PHARMA CORPORATION
    2012-07-31

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.